Trial NCT00101088

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2009-00073
Secondary IDs: R21CA112936 UCI-04-04

Last trial update was posted on 2013-01-14

MeSH Interventions

Imatinib Mesylate MTOR Inhibitors Sirolimus Temsirolimus

MeSH Conditions

Blast Crisis Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Accelerated Phase Leukemia, Myeloid, Chronic-Phase

Other Conditions

Accelerated Phase Chronic Myelogenous Leukemia Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Relapsing Chronic Myelogenous Leukemia

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID